Real world, multicentre patterns of treatment and survival in metastatic renal cell carcinoma with the UK Renal Oncology Collaborative (UK ROC): Is it time to look favourably on first‐line immunotherapy containing combinations in all IMDC groups?
英国肾脏肿瘤协作组 (UK ROC) 的转移性肾细胞癌真实世界多中心治疗模式和生存情况：是否应该对所有 IMDC 组别中的一线免疫疗法组合持积极态度？
期刊:Abdominal Radiology
影响因子:2.2
doi:10.1007/s00261-020-02876-x
Choi, Ji Whae; Hu, Rong; Zhao, Yijun; Purkayastha, Subhanik; Wu, Jing; McGirr, Aidan J; Stavropoulos, S William; Silva, Alvin C; Soulen, Michael C; Palmer, Matthew B; Zhang, Paul J L; Zhu, Chengzhang; Ahn, Sun Ho; Bai, Harrison X; McGrane, John; Frazer, Ricky; Challapalli, Amarnath; Ratnayake, Gihan; Boh, Zhaung; Clayton, Alison; Chau, Caroline; Sharma, Anand; Elgendy, Manal; Charnley, Natalie; Mohamed, Wael; Kingdon, Sarah; Protheroe, Andrew; Lydon, Anna; Halstead, Anna; Ford, Vicky; Muazzam, Iqtedar; Lee, Dawn; Melendez‐Torres, G J; Bahl, Amit
